Systematic review of comparing single-incision versus conventional laparoscopic right hemicolectomy for right colon cancer

Abstract

BackgroundSingle-incision laparoscopic right hemicolectomy (SILS) has long used in surgery for a long time. However, there is barely a systemic review related to the comparison between the SILS and the conventional laparoscopic right hemicolectomy (CLS) for the right colon cancer in the long term follow-up. Herein, we used the most recent articles to compare these two techniques by meta-analysis.MethodsWe searched PubMed, Web of Science, Cochrane Library and Wanfang databases to compare SILS with CLS for right colon cancer up to May 2019. The operative, postoperative, pathological and mid-term follow-up outcomes of nine studies were extracted and compared.ResultsA total of 1356 patients participated in 9 studies, while 653 patients were assigned to the SILS group and 703 patients were assigned to the CLS group. The patients’ baselines in the SILS group were consistent with those in the CLS group. Compared to the CLS group, the SILS group had a shorter operation duration (SMD −\u200923.49, 95%CI −\u200936.71 to −\u200910.27, P\u2009<\u20090.001, chi-square\u2009=\u200924.11), shorter hospital stay (SMD −\u20090.76, 95% `CI −\u20091.07 to −\u20090.45, P\u2009<\u20090.001, chi-square\u2009=\u20099.85), less blood loss (SMD −\u20098.46, 95% CI −\u200914.59 to −\u20092.34; P\u2009<\u20090.05; chi-square\u2009=\u20092.26), smaller incision length (SMD −\u20091.60, 95% CI −\u20092.66 to −\u20090.55, P\u2009<\u20090.001; chi-square\u2009=\u2009280.44), more lymph node harvested (SMD −\u20090.98, 95% CI −\u20091.79 to −\u20090.16, P\u2009<\u20090.05; chi-square\u2009=\u20094.61), and a longer proximal surgical edge (SMD −\u20090.51, 95% CI −\u20090.93 to −\u20090.09, P\u2009<\u20090.05; chi-square\u2009=\u20092.42). No significant difference was found in other indexes. After we removed a single large study, we performed another meta-analysis again. The operation duration in the SILS group was still better than that in the CLS group.ConclusionSILS could be a faster and more reliable approach than CLS for the right colon cancer and could accelerate patient recovery, especially for patients with a low BMI.